Children with atopic dermatitis face ‘multidimensional’ disease burden

PHOENIX — Young children with atopic dermatitis demonstrated a significant disease burden impacting their quality of life, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
“PEDISTAD, or the Pediatric Study in Atopic Dermatitis, is an ongoing, global 5-year observational registry describing the disease characteristics, atopic comorbidities and treatment patterns in pediatric patients,” Amy S. Paller, MD, principal investigator at Northwestern University’s Skin Disease Research Center, said during the presentation.

PHOENIX — Young children with atopic dermatitis demonstrated a significant disease burden impacting their quality of life, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
“PEDISTAD, or the Pediatric Study in Atopic Dermatitis, is an ongoing, global 5-year observational registry describing the disease characteristics, atopic comorbidities and treatment patterns in pediatric patients,” Amy S. Paller, MD, principal investigator at Northwestern University’s Skin Disease Research Center, said during the presentation.